%0 Journal Article
%T Minimally invasive palliative treatment of malignant tracheoesophageal fistula using cardiac septal occluder.
%A Teng L
%A Zhou F
%A Xiong X
%A Zhang H
%A Qiao L
%A Zhang Z
%A Qin Q
%A Song X
%J Langenbecks Arch Surg
%V 409
%N 1
%D 2024 Jun 1
%M 38822914
%F 2.895
%R 10.1007/s00423-024-03363-3
%X <B>BACKGROUND: </B>Tracheoesophageal fistula (TEF) especially malignant TEF (mTEF) is an uncommon yet critical medical condition necessitating immediate intervention. This life-threatening condition frequently manifests in critically ill patients who are dependent on prolonged mechanical ventilation and are unsuitable candidates for thoracotomy due to their compromised health status. The Management of these mTEF patients remain a significant challenge.This study aimed to evaluate the safety and efficacy of using a cardiac septal occluder for the closure of mTEF.<BR><B>METHODS: </B>8 patients with mTEF underwent closure surgery using atrial/ventricular septal defect (ASD/VSD) septal occluders at the Respiratory Department of HuBei Yichang Central People's Hospital from 2021 to 2023. The procedure involved percutaneous placement of the occluder through the fistula to achieve closure.<BR><B>RESULTS: </B>The placement of the cardiac septal occluder was successfully achieved with ease and efficiency in all patients. The study demonstrated that the use of cardiac septal occluder therapy in patients with mTEF can alleviate symptoms, improve quality of life, and enhance survival rates, with no significant complications observed. Furthermore, the study provided comprehensive details on surgical indications, preoperative evaluation and diagnosis, selection of occluder, methods of occlusion, and postoperative care.<BR><B>CONCLUSIONS: </B>The application of cardiac septal occluder in the treatment of mTEF is a safe and effective palliative treatment. This approach may be particularly beneficial for patients with a high risk of complications and mortality associated with traditional surgical interventions.